Abstract
The clinical diagnosis of diabetic nephropathy in an insulin-dependent patient relies on the detection of persistent proteinuria (i.e., urinary total protein excretion rate greater than 0.5 g/24h) after 10 years or more of the disease, with concomitant diabetic retinopathy and rising arterial pressure, but without signs of other renal disease, urinary tract infection or heart failure. Diabetic glomerulosclerosis is found at renal biopsy in over 90% of the cases, confirming the diagnosis (1,2). Epidemiological studies show that, cumulatively, nephropathy develops in approximately 35% of insulin-dependent patients, and it is mostly in this kind of patient that the natural history of this disorder has been outlined (1,3). Noninsulin-dependent diabetics of European origin seem to develop nephropathy less frequently than insulin-dependent patients, but because of their larger number, the actual number of patients developing end-stage renal failure is approximately the same (4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A.R. Andersen, J. S. Christiansen, J.K. Andersen, S. Kreiner, T. Deckert, Diabetic nephropathy in Type I (insulin-dependent) diabetes: an epidemiological study, Diabetologia 25:496–501 (1983).
A.C. Thomsen, The kidney in diabetes mellitus, Thesis, Copenhagen, Munksgaard (1965).
A.S. Krolewski, J.H. Warram, A.R. Christlieb, E.J. Busick, C.R. Kahn, The changing natural history of nephropathy in Type I diabetes, Am. J. Med. 78:785–794 (1985).
B. Rettig and S.M. Teusch, The incidence of end-stage renal failure in Type I and Type II diabetes mellitus, Diab. Nephropathy 3:26–27 (1984).
G.C. Viberti, R.W. Bilous, D. Mackintosh, H. Keen, Monitoring glomerular function in diabetic nephropathy. A prospective study, Am. J. Med. 74:256–264 (1983).
H.H. Parving, A.R. Andersen, U.M. Smidt, E. Hommel, E.R. Mathiesen, P.A. Svendsen, Effect of antihypertensive treatment on kidney function in diabetic nephropathy, Brit. Med. J. 294:1443–1447 (1987).
E.R. Mathiesen, B. Oxenboll, K. Johansen, P. Aa Svendsen, T. Deckert, Incipient nephropathy in Type I (insulin-dependent) diabetes, Diabetologia 26:406–410 (1984).
M.J. Wiseman, G.C. Viberti, D. Mackintosh, R.J. Jarrett, H. Keen, Glycemia, arterial pressure and microalbuminuria in Type I (insulin-dependent) diabetes mellitus, Diabetologia 26:401–405 (1984).
G.C. Viberti and H. Keen, The patterns of proteinuria in diabetes mellitus, Diabetes 33:686–692 (1984).
G.C. Viberti, R.W. Bilous, D. Mackintosh, J.J. Bending, H. Keen, Longterm correction of hyperglycemia and progression of renal failure in insulin-dependent diabetes, Br. Med. J. 286:598–602 (1983).
J.J. Bending, G.C. Viberti, P.J. Watkins, H. Keen, Intermittent clinical proteinuria and renal function in diabetes: evolution and effect of glycemic control, Br. Med. J. 292:83–86 (1986).
S. Bjorck, G. Nyberg, H. Mulec, G. Granerus, H. Herlitz, M. Aurell, Beneficial effects of angiotensin-converting enzyme inhibition on renal function in patients with diabetic nephropathy, Br. Med. J. 293:471–474 (1986).
E. Hommel, H.H. Parving, E. Mathiensen, B. Edsberg, M.D. Nielsen, J. Giese, Effect of Captopril on kidney function in insulin-dependent diabetic patients with nephropathy, Br. Med. J. 293:467–470 (1986).
A.C. Taguma, Y. Kitamoto, G. Futaki, H. Ueda, H. Monma, M. Ishizakli, H. Takalashli, H. Sekino, Y. Sasaki, Effects of Captopril on heavy proteinuria in azotemic diabetics, N. Engl. J. Med. 313:1617–1620 (1985).
R. Zatz, T. Dunn, S. Meyer, S. Anderson, H.G. Rennke, B.M. Brenner, Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension, J. Clin. Invest. 77: 1925–1930 (1986).
J. Bergstrom, Discovery and rediscovery of low-protein diet, Clin. Nephrol. 21(1):29–35 (1984).
J.B. Rosman, S. Meijer, W.J. Sluilter, P.M.T. Wee, T. Piers-Becht, A.J.M. Dunker, Prospective randomized trial of early dietary protein restriction in chronic renal failure, Lancet II:1291–1295 (1984).
P-O. Attman, H. Bucht, O. Larsson, G. Uddebom, Protein-reduced diet in diabetic renal failure, Clin. Nephrology 19:217–220 (1983).
J.J. Bending, R. Dodds, J.D. Walker, H. Keen, G.C. Viberti, Dietary protein restriction delays the progression of diabetic renal failure, Diabetologia 30:598A (1987).
K. Borch-Johnsen, P.K. Andersen, T. Deckert, The effect of proteinuria on the relative mortality in Type I (insulin-dependent) diabetes mellitus, Diabetologia 28:590–596 (1985).
K. Borch-Johnsen and S. Kreiner, Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus, Br. Med. J. 294:1651–1654 (1987).
C.E. Mogensen, Renal function changes in diabetes, Diabetes 25:872–879 (1976).
H. Keen and C. Chlouverakis, An immunoassay for urinary albumin at low concentration, Lancet II:913–916 (1963).
G.C. Viberti, J.C. Pickup, R.J. Jarrett, H. Keen, Effect of control of blood glucose on urinary excretion of albumin and B2 microglobulin in insulin-dependent diabetics, N. Engl. J. Med. 300:638–642 (1979).
C.E. Mogensen and C.K. Christensen, Predicting diabetic nephropathy insulin-dependent patients, N. Engl. J. Med. 311:89–93 (1984).
H.H. Parving, E. Hommel, E. Mathiesen, P. Skott, B. Edsberg, M. Bahnsen, M. Lauritzen, P. Hougaard, E. Lauritzen, Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes, Br. Med. J. 296:156–160 (1988).
G.C. Viberti, M.J. Wiseman, S. Redmond, Microalbuminuria: Its history and potential for prevention of clinical nephropathy in diabetes mellitus, Diab. Nephropath. 3:70–82 (1984).
B. Feldt Rasmussen and E. Mathiesen, Variability of urinary albumin excretion in incipient diabetic nephropathy, Diab. Nephropath. 3:101–103 (1984).
D.J.F. Rowe, H. Bagga, P.B. Betts, Normal variations in the rate of albumin excretion and albumin to creatinine ratios in overnight and daytime urine collections in nondiabetic children, Br. Med. J. 291:693–694 (1985).
D.L. Cohen, C.L. Close, G.C. Viberti, The variability of overnight urinary albumin excretion in insulin-dependent and normal subjects, Diab. Med. 4:437–440 (1987).
G.C. Viberti, R.D. Hill, R.J. Jarrett, U. Mahamud, H. Keen, Microalbuminuria as predictor of clinical nephropathy in insulin-dependent diabetes mellitus, Lancet I:1430–1432 (1982).
B. Feldt-Rasmussen, E.R. Mathiesen, T. Deckert, Effect of two years of strict metabolic control of progression of incipient nephropathy in insulin-dependent diabetes, Lancet II:1300–1304 (1986).
C.F. Close, On behalf of the Microalbuminuria Collaborative Study. The prevalence of at-risk microalbuminurics in a population of nonproteinuric, insulin-dependent diabetic subjects, Diabetic Med.:328A (1986).
P. Cambier, Application de la theorie de Rehberg a l’etude clinique des affections renales et du diabete, Annales de Medicine 35:273–299 (1934).
E. Fiaschi, B. Grassi, G. Andres, La funzione renale nel diabete mellito, Rassegna di fisiopatologia clinica e terapeutica 4:373–410 (1952).
J. Ditzel and M. Schwartz, Abnormal glomerular filtration rate in shortterm insulin-treated diabetic subjects, Diabetes 16:264–267 (1967).
C.E. Mogensen, Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus, Scan. J. Clin. Lab. Invest. 28:91–100 (1971).
J.S. Christiansen, J. Gammelgaard, M. Frandsen, H.H. Parving, Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics, Diabetologia 20:451–456 (1981).
M.J. Wiseman, G.C. Viberti, H. Keen, Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes, Nephron 38:257–260 (1984).
G. Stalder and R. Schmid, Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood, Ann. Paediatri. 193:129–138 (1959).
T.H. Hostetter, J.C. Troy, B.M. Brenner, Glomerular hemodynamics in experimental diabetes mellitus, Kidney Int. 19:410–415 (1981).
P.K. Jensen, J.S. Christiansen, K. Steven, H.H. Paving, Renal function in streptozotocin-diabetic rats, Diabetologia 21:409–414 (1981).
E. Hommel, E. Mathiesen, S. Arnold-Larsen, B. Edsberg, U.B. Olsen, H.H. Parving, Effects of indomethacin on kidney function in Type I (insulin-dependent) diabetic patients with nephropathy, Diabetologia 30:78–81 (1987).
M. Schambelan, S. Blake, J. Sraer, M. Bens, M.P. Nivez, F. Wahbe, Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus, J. Clin. Invest. 75:404–412 (1985).
R. Barnett, L. Scharschmidt, K.O. Young-Hyeh, D. Schlondorff, Comparison of glomerular and mesangial prostaglandin synthesis and glomerular contraction in two rat models of diabetes mellitus, Diabetes 36:1468–1475 (1987).
D.M. Brown, M.W. Steffes, P. Thibert, S. Azar, S.H. Mauer, Glomerular manifestation of diabetes in the BB rat, Metabolism 32:5131–5135 (1983).
A.F. Nakhooda, A.A. Like, C.I. Chappel, F.T. Murray, B.B. Marliss, The spontaneously diabetic Wistar rat: metabolic and morphologic studies, Diabetes 26:100–112 (1977).
A.J. Cohen, D.M. McCarthy, R.R. Rossetti, Renin secretion by the spontaneously diabetic rat, Diabetes 35:341–346 (1986).
J.I. Kreisberg and P.Y. Patel, The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells, Prostaglandins Leukotrienes Med. 11:431–442 (1983).
P.K. Jensen, K. Steven, H. Blaehr, J.S. Christiansen, H.H. Parving, Effects of indomethacin on glomerular hemodynamics in experimental diabetes, Kidney Int. 29:490–495 (1986).
P.A. Craven, M.A. Caines, F.R. DeRubertis, Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes, Metabolism 36: 95–103 (1987).
O.I. Moel, R.L. Safirstein, R.C. McEvoy, W. Hsueh, Effect of aspirin onexperimental diabetic nephropathy, J. Lab. Clin. Med. 110:300–307 (1987).
N. Bank, M.A.G. Lahorra, H.S. Aynedjian, D. Schlondorff, Vasoregulatory hormones and the hyperfiltration of diabetes, Am. J. Physiol. 254: F202-F209 (1988).
E. Esmatjes, M.R. Fernandez, I. Halpern, J. Camps, J. Gaye et al., Renal hemodynamic abnormalities in patients with short-term insulin-dependent diabetes mellitus: role of renal prostaglandins, J. Clin. Endocrinol. Metab. 60:1231–1236 (1985).
S. Gambardella, G. Pugliese, A. Napoli, S. Morano, P. Pietravalle, F. Pugliese, G. Stirati, D. Andreani, Urinary excretion of prostaglandins and renal hemodynamics in Type I (insulin-dependent) diabetes at onset: effect of piroxicam, Diabetologia 29:53A (1986).
G.C. Viberti, A. Benigni, E. Bognetti, G. Remuzzi, M.J. Wiseman, Glomerular hyperfiltration and urinary prostaglandins in insulin-dependent diabetes mellitus, In preparation.
J.S. Christiansen, B. Feldt-Rasmussen, H.H. Parving, Short-term inhibition of prostaglandin in synthesis has no effect on the elevated glomerular filtration rate of early insulin-dependent diabetes, Diabetic Med. 2:17–20 (1985).
M.J. Wiseman, R. Mangili, H. Alberetto, H. Keen, G.C. Viberti, Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics, Kidney Int. 31:1012–1018 (1987).
B.L. Kasiske, M.P. O’Donneil, W.F. Keane, Glucose-induced increases in renal hemodynamic function: possible modulation by renal prostaglandins, Diabetes 34:360–364 (1985).
D.A. Collier, D.M. Matthews, G. Beel, M.L. Watson, B.F. Clarke, Increased urinary excretion of 6-keto PGF1α and PGE2 in male insulin-dependent diabetics, Diabetic Med. 3:358A (1986).
E. Esmatjes, I. Levy, J. Gaya, F. Rivera, Renal excretion of prostaglandin E2 and plasma renin activity in Type I diabetes mellitus: relationship to normoglycemia achieved with artificial pancreas, Diabetes Care 10:428–431 (1987).
G.C. Viberti and M.J. Wiseman, The kidney in diabetes: significance of early abnormalities, Clinics in Endocrin. Metab. 15:753–783 (1986).
G.C. Viberti, R.J. Jarrett, M.J. Wiseman, Predicting diabetic nephropathy (letter), New Engl. J. Med. 311:1256–1257 (1984).
S.L. Jones, M.J. Wiseman, G.C. Viberti, H. Keen, Glomerular hyperfiltration and albuminuria — A 5-year prospective study in Type I (insulin-dependent) diabetes mellitus, Diabetologia 30:536A (1987).
M.J. Wiseman, A.J. Saunders, H. Keen, G.C. Viberti, Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes, N. Engl. J. Med. 312:617–621 (1985).
J.J. Bending, G.C. Viberti, R.W. Bilous, H. Keen, For the Kroc Collaborative Study Group. Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria, Diabetes 34 (Suppl.3):69–73 (1985).
K. Dahl-Jorgensen, O. Brinchmann-Hansen, K. Hanssen et al., Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: The Oslo Study, Br. Med. J. 293:1195–1199 (1986).
C.K. Christensen and C.K. Mogensen, Antihypertensive treatment: longterm reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function, J. Diab. Compilc. 1:45–53 (1987).
M. Marre, H. Leblanc, L. Suarez, T.T. Guyenne, J. Menard, P. Pasa, Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria, Br. Med. J. 294:1448–1452 (1987).
D.L. Cohen, R. Dodds, G.C. Viberti, Effects of protein restriction in insulin-dependent diabetics at risk of nephropathy, Br. Med. J. 294: 795–798 (1987).
R. Zatz, T.W. Meyer, H. Rennke, B.M. Brenner, Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy, Proc. Natl. Acad. Sci. USA 82:5963–5967 (1985).
M.J. Wiseman, R. Hunt, A. Goodwin, J.L. Gross, H. Keen, G.C. Viberti, Dietary composition and renal function in healthy subjects, Nephron 46:37–42 (1987).
A. Beyer-Mears, The polyol pathway, sorbinil and renal dysfunction, Metabolism 35 (Suppl. 1):46–54 (1986).
W.G. Oakley, D.A. Pyke, R.B. Tattersail, P.J. Watkin, Long-term diabetes. A clinical study of 92 patients after forty years, Q. J. Med. 43:145–156 (1974).
G.C. Viberti, H. Keen, M.J. Wiseman, Raised arterial pressure in parents of proteinuric insulin-dependent diabetics, Brit. Med. J. 295:575–577 (1987).
R. Mangili, J.J. Bending, G.S. Scott, L.K. Li, A. Gupta, G.C. Viberti, Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy, N. Engl. J. Med. 318:146–149 (1988).
A.S. Krolewski, M. Canessa, J.H. Warram, L.M.B. Laffel, R. Christlieb, W.C. Knowles, L.I. Rand, Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus, N. Engl. J. Med. 318:140–145 (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Viberti, G., Walker, J.D. (1989). Diabetic Nephropathy: Pathophysiology, Clinical Course and Susceptibility. In: Dunn, M.J., Patrono, C., Cinotti, G.A. (eds) Renal Eicosanoids. Advances in Experimental Medicine and Biology, vol 259. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5700-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5700-1_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5702-5
Online ISBN: 978-1-4684-5700-1
eBook Packages: Springer Book Archive